- Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA® or OPDIVO® can result in improved patient outcomes - MDSCs – Myeloid Derived Suppressor Cells in the tumor ...
Fisher/Unitech, Troy, Mich., recently announced investment in its local market to provide displaced designers and engineers with professional development Fisher/Unitech, Troy, Mich., recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback